The role of glucose in menopause is not directly addressed in the provided context. It is well established that hormonal changes during menopause—especially declining estrogen—can reduce insulin sensitivity, leading to higher blood glucose levels and increased risk of metabolic syndrome. MyBody-X tests like the Cardio Risk Check measure lipids and hsCRP but not glucose or insulin resistance directly. A DNA test might identify genetic variants related to glucose metabolism, but effect sizes are small and not diagnostic. Without specific studies from the context, the evidence is unclear. Women in menopause should monitor fasting glucose and HbA1c with their physician. Caveat: No home test replaces clinical evaluation.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-cd47ac88a62415d60fc5ebff